ALGN vs. IRTC: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and IRTC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ALGN dominates in value with a market cap of 12.46 billion USD, eclipsing IRTC’s 4.47 billion USD by roughly 2.79×.
With betas of 1.68 for ALGN and 1.34 for IRTC, both show similar volatility profiles relative to the overall market.
| Symbol | ALGN | IRTC |
|---|---|---|
| Company Name | Align Technology, Inc. | iRhythm Technologies, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Devices |
| CEO | Mr. Joseph M. Hogan | Mr. Quentin S. Blackford |
| Price | 171.91 USD | 139.87 USD |
| Market Cap | 12.46 billion USD | 4.47 billion USD |
| Beta | 1.68 | 1.34 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | January 30, 2001 | October 20, 2016 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and IRTC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALGN and IRTC based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- IRTC shows a negative P/E of -44.94, highlighting a year of losses, whereas ALGN at 30.88 trades on solid profitability.
- IRTC shows a negative forward PEG of -3.27, signaling expected earnings contraction, while ALGN at 2.92 maintains analysts’ projections for stable or improved profits.
| Symbol | ALGN | IRTC |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | -44.94 |
| Forward PEG Ratio (TTM) | 2.92 | -3.27 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 7.22 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | 50.98 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | 320.26 |
| EV-to-EBITDA (TTM) | 14.56 | -68.66 |
| EV-to-Sales (TTM) | 2.94 | 7.80 |
| EV-to-Free Cash Flow (TTM) | 18.56 | 346.10 |
Dividend Comparison
Neither ALGN nor IRTC currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALGN | IRTC |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and IRTC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- IRTC is highly leveraged (debt-to-equity ratio 8.49), elevating both potential gains and risks, compared to ALGN at 0.03, which maintains a steadier capital structure.
- ALGN shows “--” (minimal interest expense), but IRTC is in the red with interest coverage -16.44, signaling a net operating loss.
| Symbol | ALGN | IRTC |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 5.71 |
| Quick Ratio (TTM) | 1.08 | 5.58 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 8.49 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.79 |
| Interest Coverage Ratio (TTM) | -- | -16.44 |